Aryt
2018-01-21, 08:22
Smittkoppor som har en dödlighet på flera tiotalsprocent och en enorm smittsamhet, men som utrotades på 80-talet efter internationellt samarbete kan nu enklare skapas av den intresserade (terrororganisationer, Nordkorea m fl).
Anledningen till att sprida den kunskapen? Big pharma vill "göra bättre vaccin" (det nuvarande smittkoppsvaccinet är väldigt bra men säljer säkert dåligt då sjukdomen är utrotad förutom i enstaka högsäkerhetslab).
The study stirred alarm when Science first reported it in July 2017 because it might give would-be terrorists a recipe to construct smallpox virus, a major human scourge vanquished in 1980.
The team claims its work, funded by Tonix, a pharmaceutical company headquartered in New York City, could lead to a safer, more effective vaccine against smallpox. But safe smallpox vaccines already exist, and there appears to be no market for a horsepox-based replacement, says virologist Stephan Becker of the University of Marburg in Germany. “It simply does not add up,” Becker says. Given the apparent lack of benefits, publishing the paper was “a serious mistake,” says Thomas Inglesby, director of the Center for Health Security at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland. “The world is now more vulnerable to smallpox.”
http://www.sciencemag.org/news/2018/01/paper-showing-how-make-smallpox-cousin-just-got-published-critics-wonder-why
Nu har ytterligare ett domedagsscenario blivit närmare verklighet.
Anledningen till att sprida den kunskapen? Big pharma vill "göra bättre vaccin" (det nuvarande smittkoppsvaccinet är väldigt bra men säljer säkert dåligt då sjukdomen är utrotad förutom i enstaka högsäkerhetslab).
The study stirred alarm when Science first reported it in July 2017 because it might give would-be terrorists a recipe to construct smallpox virus, a major human scourge vanquished in 1980.
The team claims its work, funded by Tonix, a pharmaceutical company headquartered in New York City, could lead to a safer, more effective vaccine against smallpox. But safe smallpox vaccines already exist, and there appears to be no market for a horsepox-based replacement, says virologist Stephan Becker of the University of Marburg in Germany. “It simply does not add up,” Becker says. Given the apparent lack of benefits, publishing the paper was “a serious mistake,” says Thomas Inglesby, director of the Center for Health Security at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland. “The world is now more vulnerable to smallpox.”
http://www.sciencemag.org/news/2018/01/paper-showing-how-make-smallpox-cousin-just-got-published-critics-wonder-why
Nu har ytterligare ett domedagsscenario blivit närmare verklighet.